400
Participants
Start Date
July 31, 2024
Primary Completion Date
July 31, 2029
Study Completion Date
July 31, 2029
Transcarotid Artery Revascularization (TCAR)
Carotid artery revascularization treated with the FDA-cleared ENROUTE Transcarotid NPS in conjunction with the FDA-approved ENROUTE Transcarotid Stent
New York University, New York
The Mount Sinai Hospital, New York
University of Rochester, Rochester
Allegheny General Hospital, Pittsburgh
UPMC Pinnacle, Harrisburg
Lancaster General Hospital, Lancaster
St. Luke's University Hospital, Bethlehem
Sentara, Norfolk
Carilion Roanoke Memorial, Roanoke
Charleston Area Medical Center (CAMC), Charleston
Medical University of South Carolina (MUSC), Charleston
Northside Vascular, Cumming
Mount Sinai Medical Center, Miami Beach
Delray Medical Center, Delray Beach
Morton Plant Hospital, Clearwater
AdventHealth Ocala, Ocala
Valley Vascular Consultants, Huntsville
Bethesda North Hospital, Cincinnati
Indiana University, Indianapolis
Deaconess Research / Evansville Surgical Associates, Evansville
McLaren Heart & Vascular, Bay City
Corewell Health, Grand Rapids
Abbott Northwestern, Minneapolis
St. Luke's Hospital, Chesterfield
Acadiana Vascular Clinic / Our Lady Lourdes Heart Hospital, Lafayette
Memorial Hermann Southeast, Houston
Houston Methodist Sugarland, Sugarland
Cardiothoracic and Vascular Surgeons, Austin
HonorHealth, Scottsdale
Pima Heart & Vascular, Tucson
Sharp Grossmont, La Mesa
University of California, San Diego (UCSD), La Jolla
Providence Portland Medical Center-Hospital, Portland
Maine Medical Center, Portland
Beth Israel Deaconess Medical Center, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Hackensack University Medical Center, Hackensack
Lead Sponsor
Silk Road Medical
INDUSTRY